Harry L. Leider - Jun 28, 2023 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Executive Officer, Director
Signature
/s/ Harry L. Leider
Stock symbol
OCEL
Transactions as of
Jun 28, 2023
Transactions value $
$59,396
Form type
4
Date filed
6/30/2023, 04:05 PM
Previous filing
Jun 9, 2023
Next filing
Dec 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Purchase $54.4K +549K $0.10 549K Jun 28, 2023 See footnote F1
transaction OCEL Common Stock Purchase $5K +500K +91% $0.01 1.05M Jun 29, 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee.